These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1469 related articles for article (PubMed ID: 32513124)

  • 21. Postoperative nomogram for disease recurrence and cancer-specific death for upper tract urothelial carcinoma: comparison to American Joint Committee on Cancer staging classification.
    Ehdaie B; Shariat SF; Savage C; Coleman J; Dalbagni G
    Urol J; 2014 May; 11(2):1435-41. PubMed ID: 24807756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a nomogram containing the prognostic determinants of chondrosarcoma based on the Surveillance, Epidemiology, and End Results database.
    Zhang J; Pan Z; Zhao F; Feng X; Huang Y; Hu C; Li Y; Lyu J
    Int J Clin Oncol; 2019 Nov; 24(11):1459-1467. PubMed ID: 31243629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends of incidence and prognosis of upper tract urothelial carcinoma.
    Wu J; Chen S; Wu X; Mao W; Wang Y; Xu B; Zheng D; Chen M
    Bosn J Basic Med Sci; 2021 Oct; 21(5):607-619. PubMed ID: 33357210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and prognostic factors in patients with microvascular infiltration of hepatocellular carcinoma: Development and validation of a nomogram and risk stratification based on the SEER database.
    Yang D; Zhu M; Xiong X; Su Y; Zhao F; Hu Y; Zhang G; Pei J; Ding Y
    Front Oncol; 2022; 12():987603. PubMed ID: 36185206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crafting a prognostic nomogram for the overall survival rate of cutaneous verrucous carcinoma using the surveillance, epidemiology, and end results database.
    Chong S; Huang L; Yu H; Huang H; Ming WK; Ip CC; Mu HH; Li K; Zhang X; Lyu J; Deng L
    Front Endocrinol (Lausanne); 2023; 14():1142014. PubMed ID: 37051207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.
    Zuo H; Li MM
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15969-15987. PubMed ID: 37684510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer.
    Zheng P; Lai C; Yang W; Guo J; Xiao S; Chen Z
    Scand J Gastroenterol; 2020 Feb; 55(2):202-208. PubMed ID: 32008420
    [No Abstract]   [Full Text] [Related]  

  • 28. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
    Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI
    Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma.
    Zeng Q; Yao Y; Zhao M
    BMC Ophthalmol; 2021 May; 21(1):230. PubMed ID: 34030647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
    Jeldres C; Sun M; Lughezzani G; Isbarn H; Shariat SF; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Cancer; 2010 Aug; 116(16):3774-84. PubMed ID: 20564085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
    Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
    Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study.
    Zou W; Wang Z; Wang F; Zhang G; Liu R
    BMC Cancer; 2021 May; 21(1):524. PubMed ID: 33964898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
    Rouprêt M; Hupertan V; Seisen T; Colin P; Xylinas E; Yates DR; Fajkovic H; Lotan Y; Raman JD; Zigeuner R; Remzi M; Bolenz C; Novara G; Kassouf W; Ouzzane A; Rozet F; Cussenot O; Martinez-Salamanca JI; Fritsche HM; Walton TJ; Wood CG; Bensalah K; Karakiewicz PI; Montorsi F; Margulis V; Shariat SF; ;
    J Urol; 2013 May; 189(5):1662-9. PubMed ID: 23103802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and validation of a nomogram for predicting cancer-specific survival in middle-aged patients with advanced hepatocellular carcinoma: A SEER-based study.
    Li Z; Hong Q; Guo Z; Liu X; Tan C; Feng Z; Li K
    Medicine (Baltimore); 2024 Sep; 103(38):e39480. PubMed ID: 39312373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomogram for predicting cancer-specific survival of patients with clear-cell renal cell carcinoma: a SEER-based population study.
    Wang J; Wen Q; Wang X; Liu C; Zhao K; Li Y; Yang J; Liang X
    Gen Physiol Biophys; 2022 Nov; 41(6):591-601. PubMed ID: 36454119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
    Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
    Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic nomograms based on log odds of positive lymph nodes for patients with renal cell carcinoma: A retrospective cohort study.
    Zhou W; Huang C; Yuan N
    Int J Surg; 2018 Dec; 60():28-40. PubMed ID: 30389534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment.
    Syed JS; Nguyen KA; Suarez-Sarmiento A; Johnson K; Leapman MS; Raman JD; Shuch B
    BJU Int; 2018 Jan; 121(1):124-129. PubMed ID: 28972702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
    Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
    World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
    Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 74.